Literature DB >> 21545161

2-difluoromethylene-4-methylenepentanoic acid, a paradoxical probe able to mimic the signaling role of 2-oxoglutaric acid in cyanobacteria.

Xinjun Liu1, Han Chen, Erik Laurini, Yang Wang, Valentina Dal Col, Paola Posocco, Fabio Ziarelli, Maurizio Fermeglia, Cheng-Cai Zhang, Sabrina Pricl, Ling Peng.   

Abstract

2-Difluoromethylene-4-methylenepentanoic acid (DFMPA), a seemingly deviated analog of 2-oxoglutaric acid (2-OG), could surprisingly mimic its signaling function in cyanobacteria. Computer modeling revealed the favorable binding of DFMPA toward the 2-OG receptor, NtcA, via mutual conformational changes, suggesting that structural alteration of 2-OG is tolerated for it to exercise its signaling role. This extremely useful finding could be exploited for the design of affinity probes with which to study new 2-OG receptors in related signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21545161     DOI: 10.1021/ol2009544

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  3 in total

Review 1.  Non-coding RNAs and potential therapeutic targeting in cancer.

Authors:  Shusuke Toden; Timothy J Zumwalt; Ajay Goel
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-12-13       Impact factor: 10.680

2.  SAR insights into TET2 catalytic domain inhibition: Synthesis of 2-Hydroxy-4-Methylene-pentanedicarboxylates.

Authors:  Anand D Tiwari; Yihong Guan; Dale R Grabowski; Jaroslaw P Maciejewski; Babal K Jha; James G Phillips
Journal:  Bioorg Med Chem       Date:  2021-04-20       Impact factor: 3.461

3.  A Therapeutic Strategy for Preferential Targeting of TET2 Mutant and TET-dioxygenase Deficient Cells in Myeloid Neoplasms.

Authors:  Yihong Guan; Anand D Tiwari; James G Phillips; Metis Hasipek; Dale R Grabowski; Simona Pagliuca; Priyanka Gopal; Cassandra M Kerr; Vera Adema; Tomas Radivoyevitch; Yvonne Parker; Daniel J Lindner; Manja Meggendorfer; Mohamed Abazeed; Mikkeal A Sekeres; Omar Y Mian; Torsten Haferlach; Jaroslaw P Maciejewski; Babal K Jha
Journal:  Blood Cancer Discov       Date:  2020-12-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.